News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Lipid Sciences, Inc. (LIPD) Granted Two Fundamental Viral Immunotherapy Patents



8/6/2008 10:16:34 AM

PLEASANTON, CA--(Marketwire - August 06, 2008) - Lipid Sciences, Inc. (NASDAQ: LIPD) announced the issuance of two key patents covering fundamental aspects of the Company's Viral Immunotherapy platform. These two patents, 1) U.S. Patent No. 7,407,662 entitled, "Modified Viral Particles with Immunogenic Properties and Reduced Lipid Content," and 2) U.S. Patent No. 7,407,663, "Modified Immunodeficiency Virus Particles" cover the basic composition of viral particles resulting from Lipid Sciences' proprietary viral delipidation process.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES